Difference between revisions of "Cholangiocarcinoma"

Jump to navigation Jump to search
20 bytes added ,  21:54, 29 September 2015
no edit summary
Line 9: Line 9:
| LMDDx      = [[metastatic carcinoma]] - esp. luminal GI tract, [[hepatocellular carcinoma]]
| LMDDx      = [[metastatic carcinoma]] - esp. luminal GI tract, [[hepatocellular carcinoma]]
| Stains    =
| Stains    =
| IHC        = CK7 +ve, [[CK20]] +ve/-ve, [[CK19]] +ve, HepPar-1 -ve, AFP -ve, EMA +ve  
| IHC        = CK7 +ve, [[CK20]] +ve/-ve, [[CK19]] +ve, HepPar-1 -ve, [[AFP]] -ve, [[EMA]] +ve  
| EM        =
| EM        =
| Molecular  =
| Molecular  =
Line 90: Line 90:
==IHC==
==IHC==
Classic IHC pattern:<ref>{{Ref GLP|609}}</ref>
Classic IHC pattern:<ref>{{Ref GLP|609}}</ref>
*CK7 +ve.
*[[CK7]] +ve.
*CK20 +ve/-ve.
*[[CK20]] +ve/-ve.
*HepPar-1 -ve.
*HepPar-1 -ve.
*AFP -ve.<ref name=stc6dec2010>STC. 6 December 2010.</ref>
*[[AFP]] -ve.<ref name=stc6dec2010>STC. 6 December 2010.</ref>


ICC vs. HCC:<ref name=pmid19173916>[Evaluation of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma from intrahepatic cholangiocarcinoma] Dong H, Cong WL, Zhu ZZ, Wang B, Xian ZH, Yu H. Zhonghua Zhong Liu Za Zhi. 2008 Sep;30(9):702-5. Chinese. PMID 19173916.</ref>
ICC vs. HCC:<ref name=pmid19173916>[Evaluation of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma from intrahepatic cholangiocarcinoma] Dong H, Cong WL, Zhu ZZ, Wang B, Xian ZH, Yu H. Zhonghua Zhong Liu Za Zhi. 2008 Sep;30(9):702-5. Chinese. PMID 19173916.</ref>
48,833

edits

Navigation menu